Altido Therapeutics Overview
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Early Stage VC
- Investors
-
1
Altido Therapeutics General Information
Description
Developer of cell-based immunotherapies designed to treat difficult-to-treat solid tumors. The company develops CAR-TEAM therapies combining CAR-T cells and T-cell-engaging antibody molecules, with its lead program targeting glioblastoma, enabling targeted treatment of drug-resistant cancers.
Contact Information
Website
www.altidotx.comCorporate Office
- 77 4th Avenue
- Suite 330
- Waltham, MA 02451
- United States
Corporate Office
- 77 4th Avenue
- Suite 330
- Waltham, MA 02451
- United States
Altido Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 01-Aug-2026 | Completed | Pre-Clinical Trials |
Altido Therapeutics Signals
Altido Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Mass General Brigham Ventures | Venture Capital | Minority |
Altido Therapeutics FAQs
-
Where is Altido Therapeutics headquartered?
Altido Therapeutics is headquartered in Waltham, MA.
-
What is the size of Altido Therapeutics?
Altido Therapeutics has 5 total employees.
-
What industry is Altido Therapeutics in?
Altido Therapeutics’s primary industry is Biotechnology.
-
Is Altido Therapeutics a private or public company?
Altido Therapeutics is a Private company.
-
What is Altido Therapeutics’s current revenue?
The current revenue for Altido Therapeutics is .
-
Who are Altido Therapeutics’s investors?
Mass General Brigham Ventures has invested in Altido Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process